ArticlePituitary2022

Efficacy of temozolomide combined with capecitabine (CAPTEM) on refractory prolactinomas as assessed using an ex vivo 3D spheroid assay.

Atsushi Ishida et al.PubMed ↗Publisher ↗

No numbers read from the abstract.